Showing results (241-250 of 408) with videos related to
Sort By:
Pageof 41
Science Translational Medicine|May 4, 2018
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapySo-Yon Lim, Christa E Osuna, Peter T Hraber, et al.Cell Reports|April 22, 2022
Structural and functional impact by SARS-CoV-2 Omicron spike mutationsJun Zhang, Yongfei Cai, Christy L Lavine, et al.Journal of Virology|July 12, 2013
Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linkingT Schiffner, L Kong, C J A Duncan, et al.Cell Host & Microbe|July 11, 2023
Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controllerLuis M Molinos-Albert, Eduard Baquero, Mélanie Bouvin-Pley, et al.Cell|August 19, 2014
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized miceAriel Halper-Stromberg, Ching-Lan Lu, Florian Klein, et al.Biorxiv : the Preprint Server for Biology|August 24, 2021
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variantJun Zhang, Tianshu Xiao, Yongfei Cai, et al.Cell Host & Microbe|April 22, 2020
VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgAManxue Jia, Rachel A Liberatore, Yicheng Guo, et al.Journal of Virology|April 24, 2021
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic SeraSamuel J Vidal, Ai-Ris Y Collier, Jingyou Yu, et al.Nature Communications|May 18, 2025
A broad antibody with enhanced HIV-1 neutralization via bispecific antibody-mediated prepositioningSoohyun Kim, Caelan E Radford, Duo Xu, et al.Journal of Virology|April 29, 2005
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primatesSampa Santra, Michael S Seaman, Ling Xu, et al.Pageof 41